118 related articles for article (PubMed ID: 21253722)
21. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
Kono Y; Lucidarme O; Choi SH; Rose SC; Hassanein TI; Alpert E; Mattrey RF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):57-65. PubMed ID: 17296705
[TBL] [Abstract][Full Text] [Related]
22. Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound.
Cao J; Dong Y; Fan P; Mao F; Chen K; Chen R; Huang B; Cheng Y; Wang WP
Clin Hemorheol Microcirc; 2021; 78(4):365-377. PubMed ID: 33682701
[TBL] [Abstract][Full Text] [Related]
23. Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Laghi F; Catalano O; Maresca M; Sandomenico F; Siani A
Ultraschall Med; 2010 Jun; 31(3):283-8. PubMed ID: 20517816
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
25. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
[TBL] [Abstract][Full Text] [Related]
26. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial.
Wang WP; Wu Y; Luo Y; Li R; Zhou XD; Zhang J; Qian CW; Tan XY; Xu QH; Wang Y; Yuan JJ
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):370-6. PubMed ID: 19666405
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced ultrasound (CEUS) in hepatic lymphoma: retrospective evaluation in 38 cases.
Trenker C; Kunsch S; Michl P; Wissniowski TT; Goerg K; Goerg C
Ultraschall Med; 2014 Apr; 35(2):142-8. PubMed ID: 23888426
[TBL] [Abstract][Full Text] [Related]
29. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
30. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent.
Maruyama H; Kobayashi S; Yoshizumi H; Okugawa H; Akiike T; Yukisawa S; Fukuda H; Matsutani S; Ebara M; Saisho H
Clin Radiol; 2007 Jul; 62(7):668-75. PubMed ID: 17556036
[TBL] [Abstract][Full Text] [Related]
31. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
[TBL] [Abstract][Full Text] [Related]
32. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
33. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
Iwazawa J; Ohue S; Kitayama T; Sassa S; Mitani T
AJR Am J Roentgenol; 2011 Aug; 197(2):W337-42. PubMed ID: 21785062
[TBL] [Abstract][Full Text] [Related]
34. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
36. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of focal liver lesions with unenhanced and contrast enhanced low MI real time ultrasound: on-site unblinded versus off-site blinded reading.
Hohmann J; Skrok J; Basilico R; Jennett M; Müller A; Wolf KJ; Albrecht T
Eur J Radiol; 2012 Mar; 81(3):e317-24. PubMed ID: 22100374
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.
Konopke R; Kersting S; Bergert H; Bloomenthal A; Gastmeier J; Saeger HD; Bunk A
Int J Colorectal Dis; 2007 Feb; 22(2):201-7. PubMed ID: 16733650
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
[TBL] [Abstract][Full Text] [Related]
40. Treatment response evaluation with three-dimensional contrast-enhanced ultrasound for liver cancer after local therapies.
Xu HX; Lu MD; Xie XH; Xie XY; Kuang M; Xu ZF; Liu GJ; Wang Z; Chen LD; Lin MX
Eur J Radiol; 2010 Oct; 76(1):81-8. PubMed ID: 19500929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]